Ms. Melissa J Jackson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1509 N Mcewan St, Clare, MI 48617 Phone: 989-386-7721 Fax: 989-386-4505 |
Dr. Joshua Gross, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1048 N Mcewan St, Clare, MI 48617 Phone: 989-386-2900 |
John W Gross, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1048 N Mcewan St, Clare, MI 48617 Phone: 989-386-2900 Fax: 989-386-3710 |
Mrs. Judith J Cline, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10350 S Clare Ave, Clare, MI 48617 Phone: 989-386-9905 Fax: 989-386-5484 |
Weslie Michelle Smith Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1141 N Mcewan St, Clare, MI 48617 Phone: 989-386-6197 Fax: 989-386-6945 |
Bryan Victor Homberg, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1048 N Mcewan St, Clare, MI 48617 Phone: 989-386-2900 |
Imtiaz Ahmad Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1141 N Mcewan St, Clare, MI 48617 Phone: 989-386-6197 |
News Archive
BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it has received a significant order from the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) for the purchase of syringes and needles, sharps collectors and alcohol swabs to be used in national flu pandemic preparedness efforts.
In a pair of groundbreaking studies, brain scientists at Carnegie Mellon University and the University of Pittsburgh have discovered that the anatomical differences that characterize the brains of people with autism are related to the way those brains process information.
Behavioral therapy assisted by a smartphone app, delivered via telemedicine by a health coach, was an effective treatment for several symptoms of binge eating disorders, according to a study conducted by researchers from the Icahn School of Medicine at Mount Sinai and published this week in The American Journal of Psychiatry.
The first commercially available treatment in the United States for patients with late-onset Pompe disease was administered today (Wednesday, June 16) at the University of Florida.
› Verified 8 days ago